DJI46,944.35+0.83%
GDAXI23,564.01+0.50%
GSPC6,704.63+1.09%
HSI25,834.02+1.45%
IXIC22,411.50+1.38%
N22553,751.15-0.13%
AAPL253.14+1.21%
AMZN209.90+1.07%
CL95.09-3.67%
EURUSD1.1501+0.68%
GBPUSD1.3311+0.67%
GC5,003.10-1.16%
GOOG303.54+0.69%
JPM285.61+0.77%
META626.36+2.15%
MSFT399.19+0.92%
NVDA184.89+2.57%
TSLA397.34+1.57%
DJI46,944.35+0.83%
GDAXI23,564.01+0.50%
GSPC6,704.63+1.09%
HSI25,834.02+1.45%
IXIC22,411.50+1.38%
N22553,751.15-0.13%
AAPL253.14+1.21%
AMZN209.90+1.07%
CL95.09-3.67%
EURUSD1.1501+0.68%
GBPUSD1.3311+0.67%
GC5,003.10-1.16%
GOOG303.54+0.69%
JPM285.61+0.77%
META626.36+2.15%
MSFT399.19+0.92%
NVDA184.89+2.57%
TSLA397.34+1.57%
DJI46,944.35+0.83%
GDAXI23,564.01+0.50%
GSPC6,704.63+1.09%
HSI25,834.02+1.45%
IXIC22,411.50+1.38%
N22553,751.15-0.13%
AAPL253.14+1.21%
AMZN209.90+1.07%
CL95.09-3.67%
EURUSD1.1501+0.68%
GBPUSD1.3311+0.67%
GC5,003.10-1.16%
GOOG303.54+0.69%
JPM285.61+0.77%
META626.36+2.15%
MSFT399.19+0.92%
NVDA184.89+2.57%
TSLA397.34+1.57%
CYBERETIKAGLOBAL FINANCIAL INTELLIGENCE
LIVE
USA Yahoo Finance EN

Citi Lifts PT on Johnson & Johnson (JNJ) to $274 From $250 – Here’s Why

Mar 15, 2026 &03251515202631; 18:25 UTC finance.yahoo.com Trending 2/5
Read original on finance.yahoo.com ↗
↗
Positive for markets
Sentiment score: +75/100
Moderate impact Medium-term (weeks)
WHAT THIS MEANS
Citigroup raised its price target on Johnson & Johnson from $250 to $274, representing a 9.6% upside, signaling increased confidence in the pharmaceutical giant's fundamentals and growth prospects. This analyst upgrade typically reflects improved earnings expectations or positive developments in JNJ's pipeline and business segments.
AI CONFIDENCE
85% Very high
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
↑
JNJ
JNJStock
Expected to rise
Citi price target increase of 9.6% suggests positive outlook on earnings growth, pipeline strength, or dividend sustainability
↑
S&P 500
^GSPCIndex
Expected to rise
JNJ is a major S&P 500 component; positive healthcare sector sentiment supports broader market
⇅
FTSE MIB (Italy)
FTSEMIB.MIIndex
High volatility expected
Indirect positive sentiment for European healthcare stocks and pharmaceutical sector
PRICE HISTORY
Loading chart...
⚡ SUGGESTED ACTION
Consider accumulating JNJ on any pullbacks toward support levels, as the $274 PT suggests 9-10% upside potential. Monitor for confirmation through earnings reports and pipeline announcements to validate Citi's bullish thesis.
KEY SIGNALS
Analyst price target upgradeIncreased institutional confidencePotential earnings revision upsideStrong fundamental outlook
SECTORS INVOLVED
HealthcarePharmaceuticalsConsumer Health
Analysis generated on Mar 16, 2026 at 11:38 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Yahoo Finance. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

RELATED INTELLIGENCE

Monte Rosa rises on J&J collaboration for cancer therapy trial
Seeking Alpha Mar 16, 11:26 Positive
J&J hits main goal in early-stage trial for drug delivery system
Seeking Alpha Mar 13, 18:00 Positive
US drug packaging to adopt new 12-digit medicine code system
Yahoo Finance Mar 13, 09:21 Neutral
US vaccine manufacturers set to lose as RFK pushes for weaker vaccine mandates
Yahoo Finance Mar 10, 15:47 Negative
Johnson & Johnson (JNJ) Units to Pay $65 Million in Tracleer Antitrust Class Action Settlement, Reuters Reports
Yahoo Finance Mar 10, 11:15 Negative